With RM6.6b investments, Penang soon to be one of the world’s top offshore hubs to make medical devices
Malaysia dazzles as world medical devices leader
PENANG, 15 Nov 2022 : The Malaysian Investment Development Authority (Mida) and the Association of Malaysian Medical Industries (Ammi) Monday released the Ammi Medical Device Industry Status and Outlook 2021/2022 Report for the first time in Penang. This year’s Report highlights Malaysia’s medical device industry’s remarkable resilience in the face of Covid-19 pandemic challenges.
Malaysia ranks among world’s top offshore manufacturing hubs for medical devices, says report
14 November 2022: MIDA- AMMI Release of AMMI Medical Device Industry Status and Outlook 2021/2022 Report
From left: Ms Azlina Hamdan, Director of MIDA Life Sciences & Medical Technology Division; Ms Umarani Muniandy, MIDA Executive Director (Manufacturing Development -Resource); Yang Berbahagia Datuk Wira Arham Abdul Rahman, MIDA CEO; Mr Andy Lee Kuan Min, AMMI Chairman; Yang Berbahagia Dato’ Seri Dr Haji Haminnuddin, AMMI Secretary-General; Mr Michel Van Crombrugge, AMMI Treasurer.
14 November 2022, Penang – The Malaysian Investment Development Authority (MIDA) and the Association of Malaysian Medical Industries (AMMI) today released the AMMI Medical Device Industry Status and Outlook 2021/2022. The report highlighted that the Malaysian medical device industry demonstrated remarkable resilience despite COVID-19 pandemic challenges. AMMI Chairman, Mr Andy Lee presented the report to MIDA CEO, Y.Bhg Datuk Wira Arham Abdul Rahman during the joint MIDA-AMMI press conference.
5 October 2022: AMMI and YB Minister of Health
From left: Mr George Kazzi, General Manager, Baxter Malaysia; Y.Bhg. Dato’ Zamzuri bin Abdul Aziz, Deputy Secretary General (Finance), MOH; Ms Aida Basri, Government Affairs & Market Access Lead, Medtronic Malaysia; Mr CS Ching, Executive Director, AMMI; Y.Bhg. Dato’ Seri Dr Haji Haminnuddin bin Haji Abd. Hamid, Secretary General, AMMI; Mr Andy Lee, Chairman, AMMI; YB Khairy Jamaluddin, Minister of Health; Y.Bhg. Tan Sri Dato’ Seri Dr Noor Hisham bin Abdullah, Director General of Health; Dr Mohd Emil Azril Bahari Md Noor, General Manager, Government Affairs & Market Access, B. Braun; Mr Samuel Pooranakaran, Vice Chairman, AMMI.
Putrajaya, 5 October 2022 – AMMI Chairman Mr Andy Lee led Board members and Government Affairs Committee members to make a courtesy call on YB Khairy Jamaluddin, Minister of Health, today, 5 October 2022. The meeting was attended by the Top Management of the Ministry of Health (MOH), including Tan Sri Dato’ Seri Dr Noor Hisham bin Abdullah, Director General of Health, Dato’ Zamzuri bin Abdul Aziz, Deputy Secretary General (Finance), MOH and Mr Ahmad Shariff bin Hambali, Chief Executive, Medical Device Authority. YB Minister of Health, Top Management of MOH and Chief Executive of MDA responded positively to our proposal to improve the Medical Device Act (Act 737) to:-
- Include renewal/re-registration clause, which specifies auto-renewal for medical device registration (product registration);
- Confine the post-market surveillance & vigilance requirement to local cases only;
- Exclude the export of medical devices from the scope of the Medical Device Act.
At the end of the meeting, AMMI Chairman Mr Andy Lee presented a mock cheque of RM250,000 to YB Minister of Health to signify our contribution to MOH’s Covid-19 Fund (Sumbangan Perubatan KKM) on 9 March 2022 during the Omicron wave.
Note: The donation of RM250,000 to support the public healthcare system to fight against COVID-19 was approved by AMMI members in the Extraordinary General Meeting (EGM) held on 28 October 2021.
